Principal Financial Group’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,094
Closed -$290K 2174
2024
Q4
$290K Buy
9,094
+86
+1% +$2.74K ﹤0.01% 2041
2024
Q3
$260K Sell
9,008
-3,877
-30% -$112K ﹤0.01% 2056
2024
Q2
$494K Sell
12,885
-71,719
-85% -$2.75M ﹤0.01% 1962
2024
Q1
$4.97M Buy
84,604
+60,741
+255% +$3.57M ﹤0.01% 1568
2023
Q4
$1.43M Sell
23,863
-3,120
-12% -$187K ﹤0.01% 1799
2023
Q3
$1.03M Sell
26,983
-23,973
-47% -$912K ﹤0.01% 1836
2023
Q2
$4.64M Buy
50,956
+25,416
+100% +$2.32M ﹤0.01% 1550
2023
Q1
$1.68M Sell
25,540
-47,442
-65% -$3.13M ﹤0.01% 1790
2022
Q4
$3.77M Buy
72,982
+47,936
+191% +$2.48M ﹤0.01% 1618
2022
Q3
$1.71M Sell
25,046
-204
-0.8% -$13.9K ﹤0.01% 1747
2022
Q2
$1.14M Buy
25,250
+946
+4% +$42.8K ﹤0.01% 1895
2022
Q1
$1.24M Buy
24,304
+1,696
+8% +$86.2K ﹤0.01% 1938
2021
Q4
$1.07M Sell
22,608
-7,301
-24% -$345K ﹤0.01% 1970
2021
Q3
$986K Buy
29,909
+972
+3% +$32K ﹤0.01% 2005
2021
Q2
$1.83M Sell
28,937
-672
-2% -$42.5K ﹤0.01% 1934
2021
Q1
$1.27M Sell
29,609
-1,215
-4% -$52.2K ﹤0.01% 1943
2020
Q4
$1.76M Buy
30,824
+5,832
+23% +$334K ﹤0.01% 1821
2020
Q3
$754K Sell
24,992
-1,152
-4% -$34.8K ﹤0.01% 1924
2020
Q2
$854K Buy
26,144
+16,528
+172% +$540K ﹤0.01% 1858
2020
Q1
$258K Buy
9,616
+318
+3% +$8.53K ﹤0.01% 2003
2019
Q4
$285K Buy
9,298
+531
+6% +$16.3K ﹤0.01% 2062
2019
Q3
$211K Buy
8,767
+120
+1% +$2.89K ﹤0.01% 2134
2019
Q2
$219K Buy
+8,647
New +$219K ﹤0.01% 2129